| |
| |
|
| Insider
Information: |
Deerfield International Master Fund, L.p. |
| Relationship: |
*Director by Deputizat... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
285,000 |
|
|
Indirect Shares
|
28,566,834 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$93,486,690 |
|
|
| Total
Shares |
28,851,834 |
|
|
| Total
Value |
$93,486,690 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ehealth, Inc. |
EHTH |
Possible Members of 10... |
2014-08-01 |
0 |
2017-04-27 |
877,606 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
Possible Members of 10... |
2014-08-05 |
0 |
2014-08-05 |
627,267 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
Possible Members of 10... |
2014-08-06 |
0 |
2014-08-06 |
296,125 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2015-05-15 |
4,784,157 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
Possible Member of 10%... |
2015-06-11 |
0 |
2015-07-20 |
9,500,803 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Possible Member of 10%... |
2016-02-09 |
0 |
2016-02-11 |
2,039,360 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Possible Member of 10%... |
2016-02-11 |
75,000 |
2016-02-19 |
9,414,041 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
10% Owner |
2016-02-17 |
210,000 |
|
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
*Director by Deputizat... |
2017-11-30 |
0 |
2017-11-30 |
1,027,475 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2014-12-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,977,773 |
|
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2015-05-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,784,157 |
|
- |
|
| LRMR |
Larimar Therapeutics Inc |
10% Owner |
– – • |
2016-02-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,723,565 |
|
- |
|
| XNPT |
Xenoport Inc |
10% Owner |
– – • |
2016-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
75,000 |
|
- |
|
| AVXS |
Avexis, Inc. |
10% Owner |
– – • |
2016-02-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
210,000 |
|
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Possible Members of 10% Group |
– – • |
2014-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
863,212 |
531,208 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Possible Members of 10% Group |
– – • |
2014-08-06 |
4 |
A |
$0.00 |
$0 |
I/I |
501,890 |
222,839 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
*Director by Deputization |
– – • |
2017-11-30 |
4 |
S |
$1.75 |
$193,475 |
I/I |
(110,557) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
*Director by Deputization |
– – • |
2017-11-30 |
4 |
B |
$1.75 |
$193,475 |
I/I |
110,557 |
197,424 |
1.5 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-07-08 |
4 |
S |
$2.05 |
$911,638 |
I/I |
(444,341) |
6,213,945 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-30 |
4 |
S |
$2.08 |
$1,267,279 |
I/I |
(608,691) |
6,600,415 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-07-07 |
4 |
S |
$2.08 |
$415,504 |
I/I |
(198,651) |
6,409,455 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-07-01 |
4 |
S |
$2.10 |
$92,218 |
I/I |
(43,836) |
6,581,127 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-07-20 |
4 |
S |
$2.11 |
$226,320 |
I/I |
(106,024) |
6,111,957 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-07-06 |
4 |
S |
$2.12 |
$406,212 |
I/I |
(191,513) |
6,496,861 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-29 |
4 |
S |
$2.18 |
$132,084 |
I/I |
(60,695) |
6,818,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-07-17 |
4 |
S |
$2.20 |
$277,094 |
I/I |
(125,769) |
6,158,607 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-26 |
4/A |
S |
$2.24 |
$795,197 |
I/I |
(354,534) |
6,840,669 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-26 |
4 |
S |
$2.24 |
$714,168 |
I/I |
(318,534) |
6,853,826 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-25 |
4 |
S |
$2.25 |
$394,200 |
I/I |
(175,200) |
6,972,010 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-24 |
4 |
S |
$2.29 |
$606,636 |
I/I |
(263,118) |
7,037,014 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-23 |
4 |
S |
$2.35 |
$427,194 |
I/I |
(181,862) |
7,134,637 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-15 |
4 |
S |
$2.40 |
$456,447 |
I/I |
(190,141) |
3,790,301 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-16 |
4 |
S |
$2.40 |
$514,329 |
I/I |
(214,060) |
7,418,173 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Possible Member of 10% Group |
– – • |
2015-06-17 |
4 |
S |
$2.41 |
$128,936 |
I/I |
(53,605) |
7,398,284 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
